RU2013121820A - COMBINED MEDICINE FOR THE ELIMINATION OF SYMPTOMS AND TREATMENT OF ACUTE RESPIRATORY VIRAL INFECTIONS AND INFLUENZA - Google Patents

COMBINED MEDICINE FOR THE ELIMINATION OF SYMPTOMS AND TREATMENT OF ACUTE RESPIRATORY VIRAL INFECTIONS AND INFLUENZA Download PDF

Info

Publication number
RU2013121820A
RU2013121820A RU2013121820/15A RU2013121820A RU2013121820A RU 2013121820 A RU2013121820 A RU 2013121820A RU 2013121820/15 A RU2013121820/15 A RU 2013121820/15A RU 2013121820 A RU2013121820 A RU 2013121820A RU 2013121820 A RU2013121820 A RU 2013121820A
Authority
RU
Russia
Prior art keywords
paracetamol
pharmaceutically acceptable
combined preparation
acceptable salts
preparation according
Prior art date
Application number
RU2013121820/15A
Other languages
Russian (ru)
Other versions
RU2611383C2 (en
Inventor
Светлана Александровна Копатько
Original Assignee
Закрытое Акционерное Общество "Вертекс"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Закрытое Акционерное Общество "Вертекс" filed Critical Закрытое Акционерное Общество "Вертекс"
Priority to RU2013121820A priority Critical patent/RU2611383C2/en
Publication of RU2013121820A publication Critical patent/RU2013121820A/en
Application granted granted Critical
Publication of RU2611383C2 publication Critical patent/RU2611383C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1. Комбинированный препарат, содержащий парацетомол, аскорбиновую кислоту, фенирамин, фенилэфрин, а также и/или их фармацевтически приемлемые соли, отличающийся тем, что дополнительно содержит кальция глюконат и рутин, а также необязательно фармацевтически приемлемые вспомогательные вещества.2. Комбинированный препарат по п.1, отличающийся тем, что содержание активных компонентов составляет, г:3. Комбинированный препарат по п.1, отличающийся тем, что он представлен двумя составами, предназначенными для приема в дневные и вечерние часы, причем для приема в дневные часы он содержит парацетомол, фенилэфрин, а также и/или его фармацевтически приемлемые соли, аскорбиновую кислоту, кальция глюконат, рутин, а для приема в вечерние часы - парацетомол, фенилэфрин, а также и/или его фармацевтически приемлемые соли, фенирамин, а также и/или его фармацевтически приемлемые соли, аскорбиновую кислоту, кальция глюконат, рутин.4. Комбинированный препарат по п.3, отличающийся тем, что доза парацетамола в составе для приема в вечерние часы в 1,5 раза выше дозы парацетамола в составе для приема в дневные часы.5. Комбинированный препарат по п.1, отличающийся тем, что он выполнен в форме капсул, таблеток, сиропа, пакетов-саше.1. A combined preparation containing paracetamol, ascorbic acid, pheniramine, phenylephrine, and / or their pharmaceutically acceptable salts, characterized in that it additionally contains calcium gluconate and rutin, as well as optional pharmaceutically acceptable excipients. The combined preparation according to claim 1, characterized in that the content of active components is, g: 3. The combined preparation according to claim 1, characterized in that it consists of two formulations intended for daytime and evening use, and for daytime use it contains paracetamol, phenylephrine, as well as / or its pharmaceutically acceptable salts, ascorbic acid, calcium gluconate, rutin, and for evening use, paracetamol, phenylephrine, and / or its pharmaceutically acceptable salts, pheniramine, and / or its pharmaceutically acceptable salts, ascorbic acid, calcium gluconate, rutin. 4. The combined preparation according to claim 3, characterized in that the dose of paracetamol in the composition for administration in the evening is 1.5 times higher than the dose of paracetamol in the composition for administration in the afternoon. The combined preparation according to claim 1, characterized in that it is in the form of capsules, tablets, syrup, sachets.

Claims (5)

1. Комбинированный препарат, содержащий парацетомол, аскорбиновую кислоту, фенирамин, фенилэфрин, а также и/или их фармацевтически приемлемые соли, отличающийся тем, что дополнительно содержит кальция глюконат и рутин, а также необязательно фармацевтически приемлемые вспомогательные вещества.1. A combined preparation containing paracetamol, ascorbic acid, pheniramine, phenylephrine, and / or their pharmaceutically acceptable salts, characterized in that it additionally contains calcium gluconate and rutin, as well as optional pharmaceutically acceptable excipients. 2. Комбинированный препарат по п.1, отличающийся тем, что содержание активных компонентов составляет, г:2. The combined preparation according to claim 1, characterized in that the content of active components is, g: парацетамолparacetamol 0,35-0,750.35-0.75 фенилэфрина гидрохлоридphenylephrine hydrochloride 0,01-0,020.01-0.02 фенирамина малеатаfeniramine maleate 0,01-0,020.01-0.02 аскорбиновой кислотыascorbic acid 0,2-0,30.2-0.3 кальция глюконатаcalcium gluconate 0,1-0,30.1-0.3 рутинroutine 0,03-0,050.03-0.05
3. Комбинированный препарат по п.1, отличающийся тем, что он представлен двумя составами, предназначенными для приема в дневные и вечерние часы, причем для приема в дневные часы он содержит парацетомол, фенилэфрин, а также и/или его фармацевтически приемлемые соли, аскорбиновую кислоту, кальция глюконат, рутин, а для приема в вечерние часы - парацетомол, фенилэфрин, а также и/или его фармацевтически приемлемые соли, фенирамин, а также и/или его фармацевтически приемлемые соли, аскорбиновую кислоту, кальция глюконат, рутин.3. The combined preparation according to claim 1, characterized in that it is represented by two formulations intended for daytime and evening use, and for daytime use it contains paracetamol, phenylephrine, and / or its pharmaceutically acceptable salts, ascorbic acid, calcium gluconate, rutin, and for evening use - paracetamol, phenylephrine, and / or its pharmaceutically acceptable salts, pheniramine, as well as / or its pharmaceutically acceptable salts, ascorbic acid, calcium gluconate, rutin. 4. Комбинированный препарат по п.3, отличающийся тем, что доза парацетамола в составе для приема в вечерние часы в 1,5 раза выше дозы парацетамола в составе для приема в дневные часы.4. The combined preparation according to claim 3, characterized in that the dose of paracetamol in the composition for administration in the evening is 1.5 times higher than the dose of paracetamol in the composition for administration in the afternoon. 5. Комбинированный препарат по п.1, отличающийся тем, что он выполнен в форме капсул, таблеток, сиропа, пакетов-саше. 5. The combined preparation according to claim 1, characterized in that it is made in the form of capsules, tablets, syrup, sachets.
RU2013121820A 2013-05-13 2013-05-13 Combined preparation for elimination of symptoms and treating acute respiratory viral infections and influenza RU2611383C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2013121820A RU2611383C2 (en) 2013-05-13 2013-05-13 Combined preparation for elimination of symptoms and treating acute respiratory viral infections and influenza

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2013121820A RU2611383C2 (en) 2013-05-13 2013-05-13 Combined preparation for elimination of symptoms and treating acute respiratory viral infections and influenza

Publications (2)

Publication Number Publication Date
RU2013121820A true RU2013121820A (en) 2014-11-20
RU2611383C2 RU2611383C2 (en) 2017-02-21

Family

ID=53380999

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013121820A RU2611383C2 (en) 2013-05-13 2013-05-13 Combined preparation for elimination of symptoms and treating acute respiratory viral infections and influenza

Country Status (1)

Country Link
RU (1) RU2611383C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2737086C2 (en) * 2018-10-23 2020-11-24 Общество С Ограниченной Ответственностью "Валента-Интеллект" Liquid dosage form for treating and preventing influenza and arvi

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2173555C2 (en) * 1998-01-28 2001-09-20 Открытое акционерное общество "Уралбиофарм" Method of preparing anti-inflammatory analgetic agent
RU2192248C2 (en) * 1998-07-13 2002-11-10 Товарищество с ограниченной ответственностью фирма "Эйкос" Preparation "antiagrippin"
RU2185822C2 (en) * 2000-08-01 2002-07-27 Общество с ограниченной ответственностью "Фармаген" Preparation for treatment and prophylaxis of viral diseases
RU2237470C1 (en) * 2003-01-27 2004-10-10 Купсин Евгений Вениаминович Combined preparation for removing symptoms of catarrhal diseases and grippe (variants)
RU2237475C1 (en) * 2003-06-04 2004-10-10 Открытое акционерное общество "Щелковский витаминный завод" Combined preparation to remove symptoms of catarrhal diseases and grippe (variants)

Also Published As

Publication number Publication date
RU2611383C2 (en) 2017-02-21

Similar Documents

Publication Publication Date Title
RU2011153403A (en) STABILIZED COMPOSITION CONTAINING AT LEAST ONE ADRENERGIC COMPOUND
EA202190115A1 (en) FILM FORMULATIONS CONTAINING DEXMEDETOMIDINE AND METHODS FOR THEIR PREPARATION
RU2013121820A (en) COMBINED MEDICINE FOR THE ELIMINATION OF SYMPTOMS AND TREATMENT OF ACUTE RESPIRATORY VIRAL INFECTIONS AND INFLUENZA
RU2013124416A (en) DIINDOLYLMETHANE MEDICINAL PRODUCT AND ITS APPLICATION FOR TREATMENT OF INFLUENZA AND RESPIRATORY VIRAL INFECTIONS
CN103251554A (en) Stable edaravone injection and preparation method thereof
RU2010129409A (en) METHOD FOR TREATING RABBIT PSOROPTOSIS AND CARNIVOR ANIMAL OTODEKTOSIS
RU2010134748A (en) DRUG FOR CORRECTION OF EXCHANGE PROCESSES AND IMPROVEMENT OF NATURAL RESISTANCE OF ANIMAL ORGANISM
RU2015114709A (en) STABLE INJECTION COMPOSITION CONTAINING DICLOFENAC AND THIOCOLCHICOSIDE
RU2016101248A (en) LYOPHILIZED PRODUCTS BENDAMUSTINE HYDROCHLORIDE
RU2017136693A (en) METHODS FOR MAINTAINING, TREATING OR IMPROVING COGNITIVE FUNCTION
RU2013131840A (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT AND / OR PREVENTION OF OBESITY DISORDERS AND METHOD OF TREATMENT AND / OR PREVENTION OF OBESITY DISORDERS
RU2014148062A (en) INJECTION PHARMACEUTICAL COMPOSITION OF DEXKETOPROFEN AND TRAMADOL
RU2498797C2 (en) Combined preparation for influenza and acute respiratory viral infections
MX2016004464A (en) New pradimicin derivatives for the treatment of diseases caused by kinetoplastids.
RU2612011C1 (en) Enterosorbent
RU2013127881A (en) APPLICATION OF THE PHARMACEUTICAL COMPOSITION BASED ON THE SALT OF QUATERNARY PHOSPHONY AND SUBSTITUTED DINITROBENZOFUROXAN FOR THE TREATMENT OF Pyroplasmosis in Dogs and the Method of Treatment
RU2010134123A (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC DISEASES
RU2012121055A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION
CU24515B1 (en) PHARMACEUTICAL DOSAGE FORMS INCLUDING 1- [6- (MORFOLIN-4-IL) PYRIMIDIN-4-IL] -4- (1H-1,2,3-TRIAZOL-1-IL) -1H-PIRAZOL-5-OLATE OF SODIUM
RU2012134160A (en) PHARMACEUTICAL COMPOSITIONS BASED ON DIMETHYLOXOBUTYLPHOSPHONYLDIMETHYLATE (OPTIONS)
RU2021119633A (en) DEUTERATED ANALOGUES OF ACETYLEUCINE
RU2015142501A (en) MEDICINAL FORM OF DIOXOTETRAGIDROXYTETRAGHIDRONAFTALINE
RU2007140811A (en) PHARMACEUTICAL PRODUCT FOR OUTDOOR AND LOCAL USE ON THE BASIS OF STEFAGLABRIN
RU2009142700A (en) ANTI-INFLAMMATORY AND ANTI-ALLERGIC MEDICINE AND PHARMACEUTICAL COMPOSITION ON ITS BASIS
RU2011149421A (en) PHARMACEUTICAL COMPOSITION FOR INCREASING PHYSICAL PERFORMANCE